122 related articles for article (PubMed ID: 23564816)
1. Intensity-modulated radiation therapy with hypoxic sensitizer AK-2123 (sanazole) for glioblastoma multiforme using simultaneous integrated boost technique.
Yamazaki H; Nakamura S; Nishimura T; Okabe H; Aibe N; Yoshida K; Kagiya T
Anticancer Res; 2013 Apr; 33(4):1685-8. PubMed ID: 23564816
[TBL] [Abstract][Full Text] [Related]
2. Hypofractionated stereotactic radiotherapy with the hypoxic sensitizer AK-2123 (sanazole) for reirradiation of brain metastases: a preliminary feasibility report.
Yamazaki H; Nakamura S; Nishimura T; Kodani N; Tsubokura T; Kimoto T; Sihomi H; Aibe N; Yoshida K; Koizumi M; Kagiya T
Anticancer Res; 2013 Apr; 33(4):1773-6. PubMed ID: 23564833
[TBL] [Abstract][Full Text] [Related]
3. A phase I dose escalation study using simultaneous integrated-boost IMRT with temozolomide in patients with unifocal glioblastoma.
Truc G; Bernier V; Mirjolet C; Dalban C; Mazoyer F; Bonnetain F; Blanchard N; Lagneau É; Maingon P; Noël G
Cancer Radiother; 2016 May; 20(3):193-8. PubMed ID: 27117900
[TBL] [Abstract][Full Text] [Related]
4. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme.
Fuller CD; Choi M; Forthuber B; Wang SJ; Rajagiriyil N; Salter BJ; Fuss M
Radiat Oncol; 2007 Jul; 2():26. PubMed ID: 17629934
[TBL] [Abstract][Full Text] [Related]
5. Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1).
Massaccesi M; Ferro M; Cilla S; Balducci M; Deodato F; Macchia G; Valentini V; Morganti AG
Int J Clin Oncol; 2013 Oct; 18(5):784-91. PubMed ID: 22892797
[TBL] [Abstract][Full Text] [Related]
6. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma.
Morganti AG; Balducci M; Salvati M; Esposito V; Romanelli P; Ferro M; Calista F; Digesù C; Macchia G; Ianiri M; Deodato F; Cilla S; Piermattei A; Valentini V; Cellini N; Cantore GP
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):92-7. PubMed ID: 19683876
[TBL] [Abstract][Full Text] [Related]
7. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis.
Panet-Raymond V; Souhami L; Roberge D; Kavan P; Shakibnia L; Muanza T; Lambert C; Leblanc R; Del Maestro R; Guiot MC; Shenouda G
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):473-8. PubMed ID: 18554821
[TBL] [Abstract][Full Text] [Related]
8. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
McDonald MW; Shu HK; Curran WJ; Crocker IR
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
[TBL] [Abstract][Full Text] [Related]
9. Re-irradiation of recurrent glioblastoma using helical TomoTherapy with simultaneous integrated boost: preliminary considerations of treatment efficacy.
Arpa D; Parisi E; Ghigi G; Savini A; Colangione SP; Tontini L; Pieri M; Foca F; Polico R; Tesei A; Sarnelli A; Romeo A
Sci Rep; 2020 Nov; 10(1):19321. PubMed ID: 33168845
[TBL] [Abstract][Full Text] [Related]
10. Phase 2 trial of hypofractionated high-dose intensity modulated radiation therapy with concurrent and adjuvant temozolomide for newly diagnosed glioblastoma.
Iuchi T; Hatano K; Kodama T; Sakaida T; Yokoi S; Kawasaki K; Hasegawa Y; Hara R
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):793-800. PubMed ID: 24495592
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy.
Mizumoto M; Yamamoto T; Takano S; Ishikawa E; Matsumura A; Ishikawa H; Okumura T; Sakurai H; Miyatake S; Tsuboi K
Pract Radiat Oncol; 2015; 5(1):e9-16. PubMed ID: 25413424
[TBL] [Abstract][Full Text] [Related]
12. Helical tomotherapy simultaneous integrated boost provides a dosimetric advantage in the treatment of primary intracranial tumors.
Baisden JM; Sheehan J; Reish AG; McIntosh AF; Sheng K; Read PW; Benedict SH; Larner JM
Neurol Res; 2011 Oct; 33(8):820-4. PubMed ID: 22004704
[TBL] [Abstract][Full Text] [Related]
13. Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience.
Huilgol NG; Dobrowsky W; Tatsuzaki H; Chatterjee NA; Kagiya VT; Das K
Indian J Cancer; 2002 Jun; 39(2):39-44. PubMed ID: 12789723
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme.
Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT.
Iuchi T; Hatano K; Narita Y; Kodama T; Yamaki T; Osato K
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1317-24. PubMed ID: 16580493
[TBL] [Abstract][Full Text] [Related]
16. IMRT with simultaneous integrated boost and concurrent chemotherapy for nasopharyngeal cancer: plan evaluation and treatment outcome.
Kim JW; Cho JH; Keum KC; Kim JH; Kim GE; Lee JY; Kim SK; Lee CG
Jpn J Clin Oncol; 2012 Dec; 42(12):1152-60. PubMed ID: 23077243
[TBL] [Abstract][Full Text] [Related]
17. Feasibility trial for daily oral administration of the hypoxic sensitizer AK-2123 (Sanazole) in radiotherapy.
Yamazaki H; Nakamura S; Kobayashi K; Tsubokura T; Kodani N; Aibe N; Yoshida K; Kagiya T; Koizumi M; Yamada K
Anticancer Res; 2013 Feb; 33(2):643-6. PubMed ID: 23393361
[TBL] [Abstract][Full Text] [Related]
18. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain?
Hermanto U; Frija EK; Lii MJ; Chang EL; Mahajan A; Woo SY
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1135-44. PubMed ID: 17208388
[TBL] [Abstract][Full Text] [Related]
19. A Dosimetric Analysis of Preoperative Intensity-modulated and Image-guided Radiation Therapy with and without Simultaneous Integrated Boost for Locally Advanced Rectal Cancer.
Yang Y; Feng L; Wang Y; Ge R; Gong H; Xie C; Wang J; Chen J; Lan Y; Ma L
Technol Cancer Res Treat; 2015 Oct; 14(5):557-63. PubMed ID: 24988052
[TBL] [Abstract][Full Text] [Related]
20. Comparison of radiation regimens in the treatment of Glioblastoma multiforme: results from a single institution.
Azoulay M; Santos F; Souhami L; Panet-Raymond V; Petrecca K; Owen S; Guiot MC; Patyka M; Sabri S; Shenouda G; Abdulkarim B
Radiat Oncol; 2015 Apr; 10():106. PubMed ID: 25927334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
